| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.29 | 7e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.083 | 0.1 |